<DOC>
	<DOCNO>NCT00045942</DOCNO>
	<brief_summary>Patients agree participate trial screen FLT 3 mutation bone marrow exam . They physical exam , blood test , EKG , chest x-ray , bone marrow aspirate pregnancy test . Patients required weekly blood test bone marrow aspirate monthly .</brief_summary>
	<brief_title>PKC412 Patients With Acute Myeloid Leukemia Patients With Myelodysplastic Syndrome With Either Wild Type Mutated FLT3</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>4'-N-benzoylstaurosporine</mesh_term>
	<mesh_term>Staurosporine</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients : AML candidate myelosuppressive chemotherapy AML relapse disease refractory standard therapy likely require cytoreductive therapy within one month MDS subtypes RAEB , RAEBT CMML . 2 . Patients relevant FLT3ITD mutation D835Y point mutation 3 . Patients least 18 year old 4 . Patients WHO performance status 0 2 life expectancy least 3 month 5 . Patients must treat within 4 week prior therapy 6 . Written inform consent obtain accord local guideline Exclusion criterion : Patients meet follow criterion screen exclude entry study : 1 . Patients prior allogeneic , syngeneic , autologous bone marrow transplant stem cell transplant le 2 month previously . 2 . Female patient pregnant breast feeding , adult childbearing age employ effective method birth control . 3 . Concurrent severe and/or uncontrolled medical psychiatric condition may interfere completion study . 4 . Impairment gastrointestinal ( GI ) function GI disease may significantly alter absorption PKC412 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>AML</keyword>
	<keyword>MDS</keyword>
	<keyword>high risk myelodysplastic syndrome</keyword>
</DOC>